FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
Macrogenics (NASDAQ: MGNX) reported Q3 EPS of ($0.66), $0.27 better than the analyst estimate of ($0.93). Revenue for the quarter came in at $18.25 million versus the consensus estimate of $15.79 million.
MacroGenics continued the advancement of its portfolio of multiple clinical... More

